NCT00833521View on ClinicalTrials.gov

Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

February 28, 2002

Study Completion Date

February 28, 2002

Conditions
Healthy
Interventions
DRUG

Zolpidem 10 mg tablets

1 x 10 mg

DRUG

AMBIEN® 10 mg tablets

1 x 10 mg

Trial Locations (1)

15206

Novum Pharmaceutical Research Services, Pittsburgh

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00833521 - Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter